tiprankstipranks
Trending News
More News >
Dianthus Therapeutics (DNTH)
NASDAQ:DNTH
US Market

Dianthus Therapeutics (DNTH) Income Statement

Compare
316 Followers

Dianthus Therapeutics Income Statement

Last quarter (Q1 2025), Dianthus Therapeutics's total revenue was $1.16M, an increase of 33.07% from the same quarter last year. In Q1, Dianthus Therapeutics's net income was $-29.51M. See Dianthus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 6.24M$ 2.83M$ 6.42M$ 1.48M$ 0.00
Gross Profit
$ 6.24M$ 2.83M$ 6.27M$ -544.00K$ -1.98M
Operating Expenses
$ 108.10M$ 51.00M$ 36.12M$ 14.56M$ 76.72M
Depreciation and Amortization
$ 412.00K$ 355.00K$ 147.00K$ 2.02M$ 1.98M
EBITDA
$ -101.45M$ -47.82M$ -29.56M$ -13.09M$ -72.96M
Operating Income
$ -101.86M$ -48.17M$ -29.70M$ -13.09M$ -78.70M
Other Income/Expenses
$ 16.89M$ 4.62M$ 1.23M$ -23.00K$ 3.77M
Pretax Income
$ -84.97M$ -43.55M$ -28.48M$ -13.11M$ -74.94M
Net Income
$ -84.97M$ -43.55M$ -28.48M$ -13.11M$ -74.94M
Per Share Metrics
Basic EPS
$ -2.55$ -8.45$ -7.60$ -3.82$ -27.30
Diluted EPS
$ -2.55$ -8.45$ -7.60$ -3.82$ -27.30
Weighted Average Shares Outstanding
33.31M 5.15M 3.75M 3.43M 2.75M
Weighted Average Shares Outstanding (Diluted)
33.31M 5.15M 3.75M 3.43M 2.75M
Currency in USD

Dianthus Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis